Biovail To Buy Valeant
Friday, June 25, 2010 - 07:49
in Mathematics & Economics
Complex stock deal valued at about $3.3 billion will create a new firm, Valeant Pharmaceuticals.
Complex stock deal valued at about $3.3 billion will create a new firm, Valeant Pharmaceuticals.